Screeningul mamografic este principala modalitate de screening pentru cancerul de san. Cu toate acestea, screeningul mamar este departe de a fi o investigatie ideala. Interpretari fals negative au fost raportate in proportie de 10-30%. iar dintre cele 10% paciente care au necesitat reluarea investigatiei mamografice, doar 5% au fost diagnosticate cu cancer mamar, ceea ce duce la un procent de 95% rezultate fals pozitive (1 Myers ER, Moorman P, Gierisch JM, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA 2015;314:1615-34.
2 Thurfjell EL, Lernevall KA, Taube A. Benefit of independent double reading in a population-based mammography screening program. Radiology 1994;191:241-4.
3 Yankaskas BC, Klabunde CN, Ancelle-Park R, et al. International comparison of performance measures for screening mammography: can it be done? J Med Screen 2004;11:187-93. 4 Ciatto S, Ambrogetti D, Risso G, et al. The role of arbitration of discordant reports at double reading of screening mammograms. J Med Screen 2005;12:125-7.5 http://breastscreening.cancer.gov.)